NCT03846232View on ClinicalTrials.gov

Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2022

Conditions
Alzheimer Disease
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

08005

Barcelonabeta Brain Research Center, Barcelona

All Listed Sponsors
collaborator

Hospital Clinic of Barcelona

OTHER

lead

Barcelonabeta Brain Research Center, Pasqual Maragall Foundation

OTHER

NCT03846232 - Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter